Skip to content

JSPR - Jasper Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchJ

Jasper Therapeutics Inc

JSPR · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

J

JSPRJasper Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.05
52-wk low: $0.32
Prev close: $1.95
Mkt cap: $24.8M
Beta: 3.03
P/B: 17.7x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$529K

MI
Millennium
Israel Englander · Q2 2026 13F
$205K
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 35.1% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $25M

Valuation

P/B17.66

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: JSPR
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $24.84M
Beta: 3.03

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-244.2%

$100K

position

SQ

Squarepoint

Q1 2026 13F

$57K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for JSPR

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.24+35.1%

-$0.37 expected

Next report

What the street expects next

EPS expected

-$0.56

-$0.56 to -$0.56

Revenue expected

$0.00

4 analysts

Last 30 days

1up0down

Analysts raising estimates

-244.2%

ROA-112.2%

Growth

Beta3.03